February 8, 2022
Facing Esophageal Cancer in 2022Kaumudi Bhawe, PhD
Difficulty swallowing, a hoarse voice, or heartburn has led to the dreaded diagnosis of esophageal cancer. What now? Origin, Types, and Stages of Esophageal Cancer If you or a loved one face esophageal cancer, it can be helpful to start by learning more about the disease and your particular diagnosis. Then, you will be prepared to learn about esophageal cancer treatments. Esophageal cancer originates… Read more »
December 13, 2019
Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients with Locally Advanced or Metastatic Urothelial Carcinoma After Platinum-Based Therapy (RANGE): Overall Survival and Updated Results of a Randomised, Double-Blind, Phase 3 Trial BookmarkGeorge Lundberg, MD
Research paper from The Lancet curated by Editor in Chief George Lundberg, MD, who notes:
A drug called Cyramza improves progession-free survival (PFS) but not overall survival (OS) of patients with advanced bladder cancer in a phase lll clinical trial.
Go to full paper published in The Lancet.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.